[1]
H. Hongo, T. Kosaka, and M. Oya, “Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancer”, CUAJ, vol. 8, no. 11-12, pp. e921–3, Dec. 2014.